TSA as an NQO1 Specific Target Agent 47. Lewis A, Ough M, Li L, Hinkhouse MM, Ritchie JM, et al. (2004) Treatment of pancreatic cancer cells with dicumarol induces cytotoxicity and oxidative stress. Clin Cancer Res 10: 4550–4558. 48. (1984) Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease. A double blind study. Shanghai Cooperative Group for the Study of Tanshinone IIA. J Tradit Chin Med 4: 20–24. 49. Shang Q, Xu H, Huang L (2012) Tanshinone IIA: A Promising Natural Cardioprotective Agent. Evid Based Complement Alternat Med 2012: 716459. 50. Yang R, Liu A, Ma X, Li L, Su D, et al. (2008) Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol 51: 396–401. 51. Chang LC, Wu CL, Liu CW, Chuo WH, Li PC, et al. (2011) Preparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsions. J Biomed Nanotechnol 7: 558–567. 52. Benson AM, Hunkeler MJ, Talalay P (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcino- genesis and toxicity. Proc Natl Acad Sci U S A 77: 5216–5220. 53. Hao H, Wang G, Li P, Li J, Ding Z (2006) Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Pharm Biomed Anal 40: 382–388. PLoS ONE | www.plosone.org 13 July 2012 | Volume 7 | Issue 7 | e42138